-
Company Profile
Neuronetics Inc – Company Profile
Neuronetics Inc (Neuronetics) is a medical technology company that develops non-invasive therapies for psychiatric and neurological disorders. In addition, Neuronetics also offers services such as clinical training, patient education, reimbursement support, and practice support. The company conducts research and clinical trials for the clinical drugs. The company offers NeuroStar which is an unique form of TMS which helps patients in dealing with the symptoms of depression. The company has adopted a cloud based management system called HIPAA-compliant TrakStar, which collects...
Add to Basket -
Product Insights
Neuronetics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neuronetics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neuronetics Inc (Neuronetics) is a medical technology company that develops non-invasive therapies for psychiatric and neurological disorders. In addition, Neuronetics also offers services such as clinical training, patient education, reimbursement support, and practice support. The company conducts research and clinical trials for the clinical drugs. The company offers NeuroStar which is an unique form of TMS which helps patients in...
-
Sector Analysis
Deep Brain Stimulators (DBS) Market Size, Share, and Trends Analysis by Region, Product (Single Channel and Dual Channel), Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, and Others), End-user (Hospitals, Neurology Clinics, and Others), and Segment Forecast, 2022-2027
The deep brain stimulators market size was valued at US$ 1.18 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.1% during 2022-2027. The major factors contributing to the market growth includes introduction of technologically advanced deep brain stimulators and rising burden of neurological disorders. However, factors such as the complications associated with deep brain stimulation may hinder the market in focus growth. On contrary, increasing public-private initiatives for the development of efficient...
-
Sector Analysis
Neuromodulation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
The Neuromodulation Devices pipeline market research report provides comprehensive information about the Neuromodulation Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
United States Neurology Devices Market Outlook to 2025 – Hydrocephalus shunts, Interventional Neuroradiology, Minimally Invasive Neurosurgery and Others.
“What is covered in the report about the “United States Neurology Devices Market”? GlobalData’s “United States Neurology Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Neurology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hydrocephalus shunts , Interventional Neuroradiology, Minimally Invasive Neurosurgery, Neurological Diagnostic and Monitoring Equipment, Neuromodulation Devices, Neurosurgical Products and Radiosurgery Systems. The United States Neurology Devices...
-
Sector Analysis
United States Neuromodulation Devices Market Outlook to 2025
“What is covered in the report about the “United States Neuromodulation Devices Market”? GlobalData’s “United States Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators...
-
Sector Analysis
North America Neuromodulation Devices Outlook to 2025
“What is covered in the report about the “North America Neuromodulation Devices Market”? GlobalData’s “North America Neuromodulation Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the North America Neuromodulation Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Peripheral Nerve Stimulators (PNS), Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS) and Vagus Nerve Stimulators...